NovoCyte Advanteon Dx Flow Cytometer Systems 1-3 Lasers

The NovoCyte Advanteon Dx flow cytometer was first approved by NMPA in 2022. It provides up to 19 fluorescence channels and improved sensitivity and resolution which is suitable for multi-color and immunotyping use. It is also used in the clinical diagnosis of blood tumors, anemia, hemorrhagic and thrombotic diseases, solid tumors, immunodeficiency diseases, infectious diseases, ankylosing spondylitis and other diseases, and plays an important role in clinical monitoring for hematopoietic stem cell transplantation, organ transplantation.